Medications ›chlorotrianisene

chlorotrianisene

RxCUI 2397 ingredient

Contraindicated with · 28

Diagnoses12

Neoplasms, Hormone-Dependent Thrombophlebitis Phlebitis Vasculitis Thromboembolism Venous Thrombosis Thrombosis Embolism and Thrombosis Genital Diseases, Female Pregnancy Reproduction Drug Hypersensitivity

Condition families16

Peripheral Vascular Diseases Breast Neoplasms Breast Diseases Genital Diseases Neoplasms by Site Reproductive Physiological Phenomena Vascular Diseases Neoplasms Female Urogenital Diseases Skin Diseases Female Urogenital Diseases and Pregnancy Complications Skin and Connective Tissue Diseases Cardiovascular Diseases Urogenital Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 23

Diagnoses8

Menopause, Premature Climacteric Menopause Sexual Development Hypogonadism Genital Neoplasms, Male Genital Diseases, Male Genital Diseases, Female

Condition families15

Prostatic Neoplasms Ovarian Diseases Adnexal Diseases Prostatic Diseases Gonadal Disorders Urogenital Neoplasms Genital Diseases Endocrine System Diseases Neoplasms by Site Reproductive Physiological Phenomena Neoplasms Male Urogenital Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.